- Home
- ILMN vs FTAI Comparison
ILMN vs FTAI Comparison
Compare ILMN & FTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- FTAI
- Stock Information
- Founded
- ILMN 1998
- FTAI 2011
- Country
- ILMN United States
- FTAI United States
- Employees
- ILMN N/A
- FTAI N/A
- Industry
- ILMN Medical Specialities
- FTAI Misc Corporate Leasing Services
- Sector
- ILMN Health Care
- FTAI Industrials
- Exchange
- ILMN Nasdaq
- FTAI Nasdaq
- Market Cap
- ILMN 15.3B
- FTAI 16.9B
- IPO Year
- ILMN 2000
- FTAI 2015
- Fundamental
- Price
- ILMN $121.18
- FTAI $163.84
- Analyst Decision
- ILMN Hold
- FTAI Strong Buy
- Analyst Count
- ILMN 15
- FTAI 10
- Target Price
- ILMN $114.93
- FTAI $199.00
- AVG Volume (30 Days)
- ILMN 2.1M
- FTAI 1.4M
- Earning Date
- ILMN 10-30-2025
- FTAI 10-27-2025
- Dividend Yield
- ILMN N/A
- FTAI 0.85%
- EPS Growth
- ILMN N/A
- FTAI N/A
- EPS
- ILMN 4.46
- FTAI 4.36
- Revenue
- ILMN $4,288,000,000.00
- FTAI $2,344,200,000.00
- Revenue This Year
- ILMN N/A
- FTAI $50.04
- Revenue Next Year
- ILMN $2.22
- FTAI $23.67
- P/E Ratio
- ILMN $27.33
- FTAI $37.61
- Revenue Growth
- ILMN N/A
- FTAI 51.35
- 52 Week Low
- ILMN $68.70
- FTAI $75.06
- 52 Week High
- ILMN $155.99
- FTAI $194.36
- Technical
- Relative Strength Index (RSI)
- ILMN 66.82
- FTAI 45.46
- Support Level
- ILMN $118.50
- FTAI $152.44
- Resistance Level
- ILMN $126.00
- FTAI $187.70
- Average True Range (ATR)
- ILMN 5.02
- FTAI 9.93
- MACD
- ILMN 2.48
- FTAI -2.24
- Stochastic Oscillator
- ILMN 84.61
- FTAI 27.19
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About FTAI FTAI Aviation Ltd.
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.